We demonstrate that LPA treatment significantly reduced infarct volume by approximately 60% and attenuated cerebral edema at 48 h post-ischemia; This protection was accompanied by preserved BBB integrity and maintained endothelial claudin-5 expression in the ischemic territory. Here, CLDN5 is linked to ischemia.